Metastatic Malignant Neoplasm in the Lung Clinical Trials

7 recruiting

Metastatic Malignant Neoplasm in the Lung Trials at a Glance

7 actively recruiting trials for metastatic malignant neoplasm in the lung are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Houston, Rochester, and Chicago. Lead sponsors running metastatic malignant neoplasm in the lung studies include M.D. Anderson Cancer Center, Children's Oncology Group, and Mayo Clinic.

Browse metastatic malignant neoplasm in the lung trials by phase

Treatments under study

About Metastatic Malignant Neoplasm in the Lung Clinical Trials

Looking for clinical trials for Metastatic Malignant Neoplasm in the Lung? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Metastatic Malignant Neoplasm in the Lung trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Metastatic Malignant Neoplasm in the Lung clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1Phase 2

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Resectable SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Bone Sarcoma+2 more
Roswell Park Cancer Institute99 enrolled1 locationNCT03965234
Recruiting

Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)

Lung CarcinomaMetastatic Malignant Neoplasm in the Lung
Mayo Clinic40 enrolled1 locationNCT06482073
Recruiting
Phase 3

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

OsteosarcomaMetastatic Malignant Neoplasm in the LungMetastatic Osteosarcoma
Children's Oncology Group62 enrolled232 locationsNCT05235165
Recruiting
Phase 1Phase 2

Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery

Lung CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+2 more
Stanford University30 enrolled1 locationNCT03582124
Recruiting
Phase 1Phase 2

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Metastatic Malignant Solid NeoplasmAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Liver+1 more
M.D. Anderson Cancer Center40 enrolled1 locationNCT05039632
Recruiting
Not Applicable

Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer

Lung CarcinomaMetastatic Malignant Neoplasm in the LungMalignant Respiratory Tract Neoplasm
M.D. Anderson Cancer Center30 enrolled1 locationNCT03422302
Recruiting
Not Applicable

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Lung CarcinomaStage IIIA Lung Cancer AJCC v8Lung Non-Small Cell Carcinoma+3 more
Northwestern University70 enrolled1 locationNCT05802186